Comparative Study
doi: 10.1007/BF02339174.
Pharmacokinetic and pharmacodynamic characteristics of a controlled-release formulation of trazodone versus the conventional formulation in healthy volunteers
Affiliations
- PMID: 8282521
- DOI: 10.1007/BF02339174
Item in Clipboard
Comparative Study
Pharmacokinetic and pharmacodynamic characteristics of a controlled-release formulation of trazodone versus the conventional formulation in healthy volunteers
Ital J Neurol Sci.
1993 Sep.
Abstract
The pharmacokinetic and pharmacodynamic characteristics of a controlled-release (CR) formulation of trazodone were evaluated in healthy subjects who received acutely 150 mg and 75 mg of the CR trazodone and equal amounts of the conventional formulation on separate occasions. Plasma trazodone concentrations were measured by HPLC. The pharmacokinetic profile of CR trazodone was characterized by a slower increase in drug plasma levels and a lower and retarded peak plasma concentration without any modification in the total amount of trazodone absorbed over 24 hrs. The side effects were less severe and less frequent than with the conventional formulation.
Similar articles
-
A pharmacokinetic and dynamic study of single nightly doses of conventional and controlled release formulations of trazodone.Methods Find Exp Clin Pharmacol. 1991 Mar;13(2):121-7. Methods Find Exp Clin Pharmacol. 1991. PMID: 2072810
-
Pharmacokinetics of trazodone sustained-release tablets in healthy subjects: Three open-label, randomized crossover studies .Int J Clin Pharmacol Ther. 2019 Oct;57(10):520-530. doi: 10.5414/CP203482. Int J Clin Pharmacol Ther. 2019. PMID: 31262398 Clinical Trial.
-
Effects of a controlled-release formulation of trazodone on psychomotor and autonomic functions in healthy volunteers: comparison with trazodone (conventional formulation), amitriptyline and placebo.Eur J Clin Pharmacol. 1988;34(1):97-9. doi: 10.1007/BF01061427. Eur J Clin Pharmacol. 1988. PMID: 3360055 Clinical Trial.
-
Extended-release trazodone (Oleptro) for depression.Med Lett Drugs Ther. 2010 Nov 15;52(1351):91-2. Med Lett Drugs Ther. 2010. PMID: 21068704 Review.
-
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
Cited by
-
Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia.Psychopharmacology (Berl). 1994 Dec;116(4):389-95. doi: 10.1007/BF02247467. Psychopharmacology (Berl). 1994. PMID: 7701038 Clinical Trial.
-
LC-MS/MS determination of trazodone in human plasma and its pharmacokinetic study in healthy Chinese.Bioanalysis. 2025 May;17(10):661-669. doi: 10.1080/17576180.2025.2506349. Epub 2025 May 15. Bioanalysis. 2025. PMID: 40371913
-
Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability.Neurosci Appl. 2023 May 22;2:101127. doi: 10.1016/j.nsa.2023.101127. eCollection 2023. Neurosci Appl. 2023. PMID: 40655971 Free PMC article. Review.
-
Role of trazodone in treatment of major depressive disorder: an update.Ann Gen Psychiatry. 2023 Sep 2;22(1):32. doi: 10.1186/s12991-023-00465-y. Ann Gen Psychiatry. 2023. PMID: 37660092 Free PMC article. Review.